NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/15/2025
Back to search
Official data from USPTO
ADVANCED MEDICINE PARTNERS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/15/2025
Trademark type
Combined
Nice classes
40, 42
Filing date
01/26/2024
Registration date
07/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2025
Last transaction
07/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/02/2023
First use in commerce
10/02/2023
Drawing code
3
Owner type
16
Owner location
LAKE FOREST, IL
Examiner
BARREDA, AMBER KYLEE
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a design suggestive of a vertically oriented chromosome with an electrical bolt forming the junction between the two halves and the words "ADVANCED MEDICINE PARTNERS" arranged in descending order immediately to the right of the design.
Holders and representatives
Holders
JAGUAR GENE THERAPY, LLC
Advanced Medicine Partners, LLC
Representatives
J. Dickson Phillips III Robinson Bradshaw & Hinson, P.A.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Biomanufacturing for othersmanufacturing of pharmaceuticals using biological organism in the manufacturing process; custom manufacture for others of products relating to biotechnologyrecombinant proteins for use in the biotechnology industries; custom manufacture for others of cell therapy products; custom manufacture for others of gene therapy products; custom manufacture of pharmaceuticals in accordance with specific standards GMP regulations
Class 42
Contract development and manufacturing organization (CDMO) servicespharmaceutical drug development services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceuticalgene therapycell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceuticalgene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceuticalgene therapycell therapy products and materials; quality control testing of pharmaceutical products and materialsbiopharmaceutical products and materials in accordance with specifications or requirements of regulatory standards applicable in target countries; testing and validation services of biopharmaceutical products to assure compliance with global regulatory requirementsspecificationsindustry standards for pharmaceuticalcell therapy and gene therapy methods of development; technical consulting for regulatory compliance in the field of chemistry manufacturing and controls (CMC)
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/15/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/27/2025
PUBO
PUBLISHED FOR OPPOSITION
05/27/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/21/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/02/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/02/2025
GNFR
FINAL REFUSAL E-MAILED
04/02/2025
CNFR
FINAL REFUSAL WRITTEN
04/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/20/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/05/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/15/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/15/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2024
GNRT
NON-FINAL ACTION E-MAILED
08/20/2024
CNRT
NON-FINAL ACTION WRITTEN
08/20/2024
DOCK
ASSIGNED TO EXAMINER
08/12/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2024
NWAP
NEW APPLICATION ENTERED
01/26/2024
Continuous trademark protection
Get notified about every new filing that threatens ADVANCED MEDICINE PARTNERS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.